Samsung, Stanford to collaborate on sleep health solution
By HME News Staff
Updated 9:58 AM CDT, Thu April 10, 2025
STANFORD, Calif. – Samsung Electronics and Stanford University will partner on a research project with Stanford Medicine for a health solution based on Samsung’s obstructive sleep apnea feature on its Galaxy Watch, which has received de novo authorization by the U.S. Food and Drug Administration. Led by professor Robson Capasso as principal investigator and professor Clete Kushida as co-principal investigator, the joint study is designed to explore potential ways to further enhance Samsung’s sleep apnea feature, which detects signs of moderate to severe obstructive sleep apnea, to better support sleep health through timely interventions. “This collaboration with Stanford Medicine will combine our deep technological expertise with Stanford’s leading research capabilities to unlock new innovation in preventive care,” said Dr. Hon Pak, senior vice president and head of the Digital Health Team, Mobile eXperience Business, Samsung Electronics. “Together, we aim to move beyond screening to also provide more meaningful daily support that helps people better understand and manage their sleep health.” Efforts will focus on going beyond detection by leveraging AI technology for daily monitoring to sleep apnea management, empowering users with the best possible sleep tools to improve their health. The sleep apnea feature also has approval by Korea’s Ministry of Food and Drug Safety.
Comments